Most Recent
Mylan wants injunctions against Sun Pharma, Cipla over generic cholesterol drug
Intellectual Property 2019-03-06 3:17 pm By Christine Caulfield

Mylan has renewed calls for a temporary injunction against Sun Pharma pending an appeal of a ruling invalidating its patents for Lipidil, and has sued a second generic drug maker, Cipla, over the cholesterol-lowering medication.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Boehringer hits Teva with counterpunch in inhaler patent battle
Intellectual Property 2019-03-04 9:53 pm By Cat Fredenburgh

German pharmaceutical company Boehringer has struck back at a patent lawsuit brought by Teva, filing a cross-claim alleging Teva is threatening to infringe three of its patents related to its blockbuster inhaler Spiriva with the planned launch of a competing inhaler in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

D’Aquino Bros says it can prove its Scotch Whisky is the real deal
Intellectual Property 2018-12-10 9:01 pm By Christine Caulfield

Defending against a fourth trade mark infringement lawsuit by the UK’s Scotch Whisky Association, Australian liquor retailer D’Aquino Bros has told a court all of its Scotch Whisky was distilled in Scotland, and it has the paperwork to prove it.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Reckitt wants answers from AFT about Maxigesic ads
Competition & Consumer Protection 2018-11-22 8:22 pm By Miklos Bolza

Consumer goods giant Reckitt Benckiser is seeking more information after advertisements for rival AFT Pharmaceuticals’ Maxigesic painkiller were found in-store and online despite the court ordering the removal of the misleading displays earlier this month.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

AFT Pharma ordered to pull misleading Maxigesic ads
Competition & Consumer Protection 2018-11-09 8:44 pm By Miklos Bolza

AFT Pharmaceuticals has been ordered to pull advertisements for its painkiller Maxigesic after the Federal Court ruled in favour of rival Reckitt Benckiser, finding the ads breached Australian Consumer Law.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?